ALX Oncology Holdings Inc. (ALXO) Misses Q2 EPS by 2c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q2 EPS of ($0.76), $0.02 worse than the analyst estimate of ($0.74).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Jefferies Downgrades Mixue Group (2097:HK) to Hold
• Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold